These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27027386)

  • 21. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
    Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
    JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of neutralizing antibodies against hepatitis C virus in patients who were treated with pegylated-interferon plus ribavirin.
    Sasayama M; Deng L; Kim SR; Ide Y; Shoji I; Hotta H
    Kobe J Med Sci; 2010 Sep; 56(2):E60-6. PubMed ID: 21063147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
    Kimura Y; Hayashida K; Ishibashi H; Niho Y; Yanagi Y
    J Med Virol; 2000 May; 61(1):37-43. PubMed ID: 10745230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou].
    Liu S; Cheng M; Mu M; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):251-4. PubMed ID: 25173221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
    Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological features of chronic hepatitis C in haemodialysis patients.
    Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
    Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different reactivity against HCV proteins (RIBA 3) according to progression of liver damage.
    Barbacini IG; Goldoni E; De Sanctis GM; Margiotta MC; Sebastiano D; D'Errico DA; Altavilla N; Magnapera A; Rivanera D; Lilli D; Ippoliti F; Grimaldi F; Mancini C; Chircu LV
    Panminerva Med; 1998 Dec; 40(4):269-72. PubMed ID: 9973819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus genotypes and risk of cirrhosis in southern Italy.
    Osella AR; Misciagna G; Guerra V; Elba S; Buongiorno G; Cavallini A; Di Leo A; Sonzogni L; Mondelli MU; Silini EM
    Clin Infect Dis; 2001 Jul; 33(1):70-5. PubMed ID: 11389497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
    Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
    Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L; Shoukry NH; Grá B; Amador-Cañizares Y; Helle F; Bédard N; Guerra I; Drouin C; Dubuisson J; González-Horta EE; Martínez G; Marante J; Cinza Z; Castellanos M; Dueñas-Carrera S
    J Viral Hepat; 2009 Mar; 16(3):156-67. PubMed ID: 19017255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
    Lavillette D; Morice Y; Germanidis G; Donot P; Soulier A; Pagkalos E; Sakellariou G; Intrator L; Bartosch B; Pawlotsky JM; Cosset FL
    J Virol; 2005 May; 79(10):6023-34. PubMed ID: 15857988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C.
    Grigorescu M;
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):45-50. PubMed ID: 19337633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.
    Raghuraman S; Park H; Osburn WO; Winkelstein E; Edlin BR; Rehermann B
    J Infect Dis; 2012 Mar; 205(5):763-71. PubMed ID: 22293431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
    Shehata MA; Abou El-Enein A; El-Sharnouby GA
    Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.